The use of high dose aprotinin in liver transplantation: The influence on fibrinolysis and blood loss

This publication has 27 references indexed in Scilit:

• Human plasma extrinsic pathway inhibitor activity: II. Plasma levels in disseminated intravascular coagulation and hepatocellular disease
  Blood, 1989
• SYSTEMIC EFFECTS OF TISSUE PLASMINOGEN ACTIVATOR-ASSOCIATED FIBRINOLYSIS AND ITS RELATION TO THROMBIN GENERATION IN ORTHOTOPIC LIVER TRANSPLANTATION
  Transplantation, 1989
• Reduction of Blood Transfusion Requirement in Open Heart Surgery by Administration of High Doses of Aprotinin - Preliminary Results
  The Thoracic and Cardiovascular Surgeon, 1989
• Fibrinolysis during liver transplantation in humans: role of tissue- type plasminogen activator
  Blood, 1988
• EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY
  The Lancet, 1987
• The pathogenesis of accelerated fibrinolysis in liver cirrhosis: a critical role for tissue plasminogen activator inhibitor
  Blood, 1987
• Hemostasis and Fibrinolysis in Severe Liver Failure and Their Relation to Hemorrhage
  Hepatology, 1986
• The Coagulation Disorder of Orthotopic Hepatic Transplantation
  Seminars in Thrombosis and Hemostasis, 1977
• Liver Transplantation in Man--IV, Haemorrhage and Thrombosis
  BMJ, 1969
• Coagulation During and After Orthotopic Transplantation of the Human Liver
  Archives of Surgery, 1969